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Purpose: To test whether red blood cell (RBC) membrane composition is modified in 
abdominal aortic aneurysms (AAA) patients.  
Experimental design: RBC membrane extracts from AAA patients (aortic diameter >3 cm, 
n = 7) and control subjects (n = 4) were analyzed by a label-free quantitative MS-based 
strategy, using spectral count data. Additional validation was performed by western-blot. 
Results: Data analysis based on spectral count from MS/MS-based experiments provided us 
a signature of 39 proteins differentially expressed in RBC membranes between AAA and 
controls (changes equal/over 1.515-fold; p-values equal/lower 0.05). MS data revealed 
altered levels of structural membrane proteins (e.g. spectrins and ankyrin), components of 
the degradation machinery (proteasome subunits), and oxidative stress related proteins (e.g. 
catalase and peroxiredoxin-2) among others. Decreased catalase and peroxiredoxin-2 
expression in RBC membrane of AAA patients compared to controls were further validated 
by Western blot, confirming the proteomic results. 
Conclusions and clinical relevance: RBCs membrane protein composition is altered in 
AAA patients, which could be involved in the pathological role of RBCs in aortic tissue and 
become potential targets to prevent AAA progression. 
Clinical Relevance 
Abdominal aortic aneurysm (AAA) is a chronic disease characterized by the presence of a 
chronic intraluminal thrombus, medial degradation, and an adventitial response. Red blood 
cells (RBCs) in intraluminal thrombus could contribute to oxidative stress, while RBC in 
adventitia may induce the recruitment of phagocytes. Since both pathological mechanisms 
could be favored by alterations in the membrane protein composition of RBCs, we 
addressed a proteomic analysis of RBCs membranes from AAA patients and controls by a 
label-free quantitative MS-based strategy. MS data revealed altered levels of structural 
proteins, components of the protein degradation machinery, and antioxidant proteins. In this 
respect, previous studies on RBC composition of chronic thrombus in AAA but also acute 
thrombus in patients with atherothrombosis (myocardial infarction/acute coronary 
syndromes), have suggested that oxidative stress could be linked to the clinical 
consequences and therapeutic options in these diseases. Understanding the complex cellular 
and molecular mechanisms underlying redox balance associated to RBCs could help to 
define novel potential therapeutic targets to decrease AAA risk. 
 
Introduction 
 Abdominal aortic aneurysm (AAA) occurs in up to 9% of adults older than 65 years of age, 
causing about 1–2% of male deaths in Western countries. AAA is a chronic disease 
characterized by the presence of a chronic red blood cell RBC-rich (where RBC is red blood 
cell) intraluminal thrombus (ILT), medial degradation, and an adventitial response [1]. Main 
mechanisms involved in AAA development and progression are proteolysis and oxidative 
stress, associated to the presence of neutrophils and RBC in ILT, and phagocytosis and 
immune response of the arterial wall. The trapping of RBCs within the ILT of AAA may 
lead to hemolysis and subsequent release of hemoglobin (Hb), heme, and finally, iron, 
which generates ROS via the Fenton reaction. Hydrogen peroxide (H2O2) produced by 
autoxidation of Hb is a predominant ROS in RBCs [2]. In addition, RBCs and iron deposits 
associated to phagocytes are observed in the aneurismal wall, potentially favoring the 
recruitment of monocytes through adventitial neovessels [1]. Moreover, this local RBC 
retention may impede iron recycling and erythropoiesis leading to anemia, which is a 
predictor of long-term mortality in patients with AAA [3]. 
Since mature RBCs do not contain RNA or DNA, proteomics has been previously used to 
understand the role of RBCs in different diseases [4]. Moreover, as human RBCs have a 120 
days lifespan, alterations on RBC proteins could afford interesting information on the long-
term status of the body in chronic diseases [4].A main difficulty to analyze RBCs proteome 
is the large dynamic range for cellular protein concentration, mainly the high concentration 
of cytosolic Hb (97%). One alternative is analyzing the membrane fraction, which his not 
devoid of some technical difficulties (e.g.proteins from other compartments) [4]. The 
interest of analyzing the plasma membrane proteome of RBCs is due to the fact that 
modification of proteins at this localization could impact: (i) RBCs deformability needed for 
their flow and the delivery of oxygen to tissues; (ii) RBC prooxidant activities, and (iii) 
RBC removal through erytrophagocytosis [2]. Although RBCs play a key role in chronic 
vascular remodeling, no previous proteomic studies have been performed in RBCs from 
 
patients with AAA. In the present study, we aimed to characterize the differential protein 
composition of RBC membrane extracts from AAA patients and controls. 
For that purpose, RBCs were obtained from blood of 20 AAA patients (aortic diameter >3 
cm) and ten controls (aortic diameter <3 cm confirmed by ultrasound without significant 
differences in sex, age, or risk factors). Seven AAA and four control RBC samples were 
analyzed by proteomics, while all RBC samples were used for final validation. The local 
IISEthical Committee approves the study and informed consent of all participating subjects 
was obtained. Membrane proteins isolated from erythrocytes were run in 3.5% stacking gels 
(Fig. 1A) and were analyzed by a label-free quantitative MS based strategy; using spectral 
count data (see Supporting Information). Data analysis based on spectral count data from 
MS/MS-based experiments provided us a list of 39 proteins with statistical significance 
between AAA patients and controls (changes equal/over 1.5-fold; p 0.05, Table 1), from the 
141 identified proteins. Differential quantitative analysis shown in Fig.1B by a volcano 
plot,where pointed lines limit the points corresponding to over- or downregulated proteins in 
AAA patients with respect to control subjects. Initial MS data show that the most abundant 
identified protein in all extracts was the band 3 anion transport (not shown), which is the 
highest abundant protein in plasma membrane from RBCs, suggesting the purity of our 
starting sample. However, we cannot discard the potential contribution of contaminants 
from other cell types (e.g. reticulocytes) [5]. Among others, MS data revealed altered levels 
of structural membrane proteins (e.g. ankyrin), components of the degradation machinery 
(e.g. proteasome subunits) and oxidative stress related proteins (e.g. catalase and 
peroxiredoxin-2 (Prdx-2)) in RBCs from AAA patients (Table 1). Due to the importance of 
oxidative stress in AAA [6,7], we validated catalase and Prdx-2 in samples from ten controls 
and 20 AAA patients by Western blot. Equal amounts of proteins (20 g) were resolved as 
previously reported [6]. As observed in Fig. 2, decreased catalase and Prdx-2 expression 
was observed in RBCs membrane extracts from AAA patients compared to controls, 
confirming the initial proteomic results. Catalase and Prdx-2 are mainly expressed in the 
cytosol, where no differences were found. It is important to note that whereas intracellular 
ROS are neutralized by the highly abundant cytosolic antioxidant systems in RBCs 
(catalase, glutathione peroxidase, and peroxiredoxin), ROS associated to hemoglobin 
oxidation (among them heme degradation products) are mainly located to the membrane [2]. 
Interestingly, the increase in heme degradation products has been found in the membrane 
fraction of senescent RBCs and of pathological RBCs (with less stable Hb) [8]. More 
recently, neutralization of membrane ROS by Prdx-2 was proposed as the underlying 
mechanism explaining the increase in heme degradation products in Prdx-2 KO mice [9]. 
All these data highlight the importance of a redox dysbalance at this localization. 
The clinical relevance of our study could be associated to the potential role of RBC number 
and related anemia as a strong diagnostic/prognostic marker of AAA patients [3]. The 
recently described diminution of RBC number in AAA patients could be the result of both 
decreased RBC production and/or increased RBC clearance. In one hand, we recently 
observed decreased iron availability for RBC production associated to increase 
inflammatory conditions and tisular retention in AAA patients [3]. In the other hand, 
changes in RBC membrane composition could affect RBC clearance/elimination. 
Senescent/damaged RBCs are cleared by phagocytosis and it is generally assumed that 
aging-associated changes in membrane structure are caused by oxidative damage [10]. In 
addition to senescence, RBCs may die by eryptosis, a programmed suicidal death program 
characterized by cell membrane scrambling and cell shrinkage, with exposure of 
phosphatidylserine at the cell surface [11]. Oxidative stress activates Ca2+ sensitive K+ 
channels in the erythrocyte cell membrane presumably via generation of prostaglandins, 
which stimulate eryptosis [12]. We have shown herein altered expression in antioxidant 
proteins, along with structural proteins and several components of the proteasome complex, 
in RBC membrane of AAA patients. In the same line, when recent studies have analyzed the 
interactome of RBCs to address main pathways involved in RBC vitality, oxidative stress 
along with proteins of the proteasome machinery has been included [13]. Thus it could be 
speculated that the decrease in RBC number and associated anemia in AAA patients could 
be due, at least in part, to the increased clearance of “damaged” RBCs (or RBCs with altered 
membrane protein composition). In this respect, a decreased activity of membrane bound 
antioxidant systems has been suggested to potentially decrease RBC lifespan [14]. 
Accordingly, Prdx-2 KO mice display haemolytic anemia [15]. Finally, in addition to the 
important role of altered RBC membrane composition associated to the role of RBC number 
as diagnostic/prognostic biomarker in AAA, our study could help to understand pathological 
mechanisms involved in AAA of potential therapeutic interest. Among them, decreased 
 
expression of antioxidant systemsinRBCsmembranefromAAApatientscouldimpact: (i) 
prooxidant reactions in cells near them in AAA tissue (e.g. neutrophils in ILT and vascular 
smooth muscle cells/VSMCs in wall) and (ii) phagocyte recruitment to AAA tissue for 
removal of redox-induced senescent RBCs. Thus, increasing the expression or activity of 
these antioxidant systems (e.g. Prdx-2, catalase) could be a therapeutic option in the 
treatment of AAA. In agreement, specific catalase overexpression in VSMCs has been 
recently demonstrated to prevent experimental AAA formation [16]. 
On the whole, our proteomic study shows that RBC membrane protein composition is 
altered in AAA, although future studies should be performed to understand the functional 
consequences of the modification of proteins in the membrane of RBC in AAA patients. 
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Table 1. List of proteins differentially expressed in membrane fractions from human 
erythrocytes 
 
a) Accession code according to SwissProt database. b) Fold change (FC) and its associated 
p-value in each group (CT, control subjects group). Negative FC values indicates 
downregulation in patients. If FC is unique, this indicates black-and-white regulation, as 




Figure 1. (A) General schedule showing the procedure followed. (B) Volcano plot provided 
by the proteomic quantitative analysis. Red and blue pointed lines represent the protein 
candidates’ thresholds (over- and downregulated proteins in patients versus controls, 
respectively). Catalase and peroxiredoxin-2 (Prdx2) are two of the differential proteins 









Figure 2. RBCs membrane composition from AAA patients and controls. (A) 
Representative Western blot using anticatalase (abcam) and antiperoxiredoxin 2 (santa cruz) 
antibodies on RBC membrane and cytosolic extracts isolated from controls (CT) and 
patients (AAA). (B) Densitometric analysis from ten controls and 20 AAA patients (*p < 
0.05 versus CT). 
 
